nodes	percent_of_prediction	percent_of_DWPC	metapath
Propericiazine—Quetiapine—H1F0—hematologic cancer	0.00154	0.172	CrCbGaD
Propericiazine—Acepromazine—SLC22A1—hematologic cancer	0.000847	0.095	CrCbGaD
Propericiazine—Thioproperazine—SLC22A1—hematologic cancer	0.000828	0.0928	CrCbGaD
Propericiazine—Pipotiazine—SLC22A1—hematologic cancer	0.000814	0.0913	CrCbGaD
Propericiazine—Thiothixene—SLC22A1—hematologic cancer	0.000814	0.0913	CrCbGaD
Propericiazine—Clomipramine—GSTP1—hematologic cancer	0.000696	0.0781	CrCbGaD
Propericiazine—Chlorpromazine—SLC22A1—hematologic cancer	0.000442	0.0495	CrCbGaD
Propericiazine—Domperidone—ABCB1—hematologic cancer	0.000329	0.0369	CrCbGaD
Propericiazine—Vomiting—Hydroxyurea—hematologic cancer	0.000298	0.000347	CcSEcCtD
Propericiazine—Angioedema—Triamcinolone—hematologic cancer	0.000297	0.000346	CcSEcCtD
Propericiazine—Body temperature increased—Alitretinoin—hematologic cancer	0.000296	0.000345	CcSEcCtD
Propericiazine—Rash—Hydroxyurea—hematologic cancer	0.000295	0.000344	CcSEcCtD
Propericiazine—Confusional state—Etoposide—hematologic cancer	0.000295	0.000344	CcSEcCtD
Propericiazine—Dermatitis—Hydroxyurea—hematologic cancer	0.000295	0.000343	CcSEcCtD
Propericiazine—Constipation—Gemcitabine—hematologic cancer	0.000293	0.000341	CcSEcCtD
Propericiazine—Body temperature increased—Ifosfamide—hematologic cancer	0.000293	0.000341	CcSEcCtD
Propericiazine—Diarrhoea—Vinorelbine—hematologic cancer	0.000292	0.00034	CcSEcCtD
Propericiazine—Infection—Etoposide—hematologic cancer	0.000291	0.000339	CcSEcCtD
Propericiazine—Hypersensitivity—Thalidomide—hematologic cancer	0.00029	0.000338	CcSEcCtD
Propericiazine—Nausea—Melphalan—hematologic cancer	0.00029	0.000338	CcSEcCtD
Propericiazine—Oedema—Prednisolone—hematologic cancer	0.000289	0.000336	CcSEcCtD
Propericiazine—Asthma—Epirubicin—hematologic cancer	0.000289	0.000336	CcSEcCtD
Propericiazine—Tachycardia—Etoposide—hematologic cancer	0.000286	0.000333	CcSEcCtD
Propericiazine—Eosinophilia—Epirubicin—hematologic cancer	0.000286	0.000333	CcSEcCtD
Propericiazine—Body temperature increased—Vincristine—hematologic cancer	0.000286	0.000333	CcSEcCtD
Propericiazine—Dyspnoea—Cisplatin—hematologic cancer	0.000285	0.000332	CcSEcCtD
Propericiazine—Erectile dysfunction—Methotrexate—hematologic cancer	0.000284	0.000331	CcSEcCtD
Propericiazine—Hyperhidrosis—Etoposide—hematologic cancer	0.000283	0.000329	CcSEcCtD
Propericiazine—Nausea—Lenalidomide—hematologic cancer	0.000282	0.000328	CcSEcCtD
Propericiazine—Tachycardia—Prednisolone—hematologic cancer	0.000282	0.000328	CcSEcCtD
Propericiazine—Photosensitivity reaction—Methotrexate—hematologic cancer	0.000281	0.000328	CcSEcCtD
Propericiazine—Hypokalaemia—Doxorubicin—hematologic cancer	0.000281	0.000327	CcSEcCtD
Propericiazine—Hyperhidrosis—Prednisolone—hematologic cancer	0.000279	0.000325	CcSEcCtD
Propericiazine—Hypersensitivity—Carmustine—hematologic cancer	0.000279	0.000325	CcSEcCtD
Propericiazine—Diarrhoea—Thiotepa—hematologic cancer	0.000279	0.000325	CcSEcCtD
Propericiazine—Body temperature increased—Irinotecan—hematologic cancer	0.000278	0.000324	CcSEcCtD
Propericiazine—Body temperature increased—Mitoxantrone—hematologic cancer	0.000278	0.000324	CcSEcCtD
Propericiazine—Nausea—Hydroxyurea—hematologic cancer	0.000278	0.000324	CcSEcCtD
Propericiazine—Vomiting—Bortezomib—hematologic cancer	0.000278	0.000324	CcSEcCtD
Propericiazine—Pneumonia—Methotrexate—hematologic cancer	0.000277	0.000322	CcSEcCtD
Propericiazine—Hypersensitivity—Alitretinoin—hematologic cancer	0.000276	0.000322	CcSEcCtD
Propericiazine—Vomiting—Bleomycin—hematologic cancer	0.000276	0.000321	CcSEcCtD
Propericiazine—Rash—Bortezomib—hematologic cancer	0.000276	0.000321	CcSEcCtD
Propericiazine—Dermatitis—Bortezomib—hematologic cancer	0.000275	0.000321	CcSEcCtD
Propericiazine—Drowsiness—Methotrexate—hematologic cancer	0.000275	0.00032	CcSEcCtD
Propericiazine—Hypotension—Etoposide—hematologic cancer	0.000274	0.000318	CcSEcCtD
Propericiazine—Rash—Bleomycin—hematologic cancer	0.000273	0.000318	CcSEcCtD
Propericiazine—Dermatitis—Bleomycin—hematologic cancer	0.000273	0.000318	CcSEcCtD
Propericiazine—Hypersensitivity—Ifosfamide—hematologic cancer	0.000273	0.000318	CcSEcCtD
Propericiazine—Vomiting—Vinorelbine—hematologic cancer	0.000271	0.000316	CcSEcCtD
Propericiazine—Body temperature increased—Gemcitabine—hematologic cancer	0.000271	0.000316	CcSEcCtD
Propericiazine—Dry mouth—Triamcinolone—hematologic cancer	0.000271	0.000315	CcSEcCtD
Propericiazine—Angioedema—Dexamethasone—hematologic cancer	0.00027	0.000314	CcSEcCtD
Propericiazine—Angioedema—Betamethasone—hematologic cancer	0.00027	0.000314	CcSEcCtD
Propericiazine—Diarrhoea—Thalidomide—hematologic cancer	0.00027	0.000314	CcSEcCtD
Propericiazine—Rash—Vinorelbine—hematologic cancer	0.000269	0.000313	CcSEcCtD
Propericiazine—Dermatitis—Vinorelbine—hematologic cancer	0.000269	0.000313	CcSEcCtD
Propericiazine—Asthma—Doxorubicin—hematologic cancer	0.000267	0.000311	CcSEcCtD
Propericiazine—Hypersensitivity—Vincristine—hematologic cancer	0.000266	0.00031	CcSEcCtD
Propericiazine—Triflupromazine—ABCB1—hematologic cancer	0.000266	0.0298	CrCbGaD
Propericiazine—Oedema—Triamcinolone—hematologic cancer	0.000266	0.000309	CcSEcCtD
Propericiazine—Eosinophilia—Doxorubicin—hematologic cancer	0.000264	0.000308	CcSEcCtD
Propericiazine—Arrhythmia—Prednisone—hematologic cancer	0.000264	0.000307	CcSEcCtD
Propericiazine—Infection—Triamcinolone—hematologic cancer	0.000264	0.000307	CcSEcCtD
Propericiazine—Photosensitivity reaction—Epirubicin—hematologic cancer	0.000263	0.000307	CcSEcCtD
Propericiazine—Weight increased—Epirubicin—hematologic cancer	0.000263	0.000306	CcSEcCtD
Propericiazine—Insomnia—Prednisolone—hematologic cancer	0.000261	0.000304	CcSEcCtD
Propericiazine—Dyspnoea—Etoposide—hematologic cancer	0.000261	0.000304	CcSEcCtD
Propericiazine—Hyperglycaemia—Epirubicin—hematologic cancer	0.00026	0.000303	CcSEcCtD
Propericiazine—Somnolence—Etoposide—hematologic cancer	0.00026	0.000303	CcSEcCtD
Propericiazine—Nausea—Bortezomib—hematologic cancer	0.00026	0.000302	CcSEcCtD
Propericiazine—Hypersensitivity—Mitoxantrone—hematologic cancer	0.000259	0.000302	CcSEcCtD
Propericiazine—Hypersensitivity—Irinotecan—hematologic cancer	0.000259	0.000302	CcSEcCtD
Propericiazine—Tachycardia—Triamcinolone—hematologic cancer	0.000259	0.000302	CcSEcCtD
Propericiazine—Vomiting—Thiotepa—hematologic cancer	0.000259	0.000302	CcSEcCtD
Propericiazine—Diarrhoea—Carmustine—hematologic cancer	0.000259	0.000302	CcSEcCtD
Propericiazine—Pneumonia—Epirubicin—hematologic cancer	0.000259	0.000301	CcSEcCtD
Propericiazine—Acepromazine—ALB—hematologic cancer	0.000258	0.0289	CrCbGaD
Propericiazine—Nausea—Bleomycin—hematologic cancer	0.000258	0.0003	CcSEcCtD
Propericiazine—Drowsiness—Epirubicin—hematologic cancer	0.000257	0.0003	CcSEcCtD
Propericiazine—Rash—Thiotepa—hematologic cancer	0.000257	0.000299	CcSEcCtD
Propericiazine—Dermatitis—Thiotepa—hematologic cancer	0.000257	0.000299	CcSEcCtD
Propericiazine—Hyperhidrosis—Triamcinolone—hematologic cancer	0.000257	0.000299	CcSEcCtD
Propericiazine—Diarrhoea—Alitretinoin—hematologic cancer	0.000257	0.000299	CcSEcCtD
Propericiazine—Agranulocytosis—Methotrexate—hematologic cancer	0.000257	0.000299	CcSEcCtD
Propericiazine—Diarrhoea—Ifosfamide—hematologic cancer	0.000254	0.000295	CcSEcCtD
Propericiazine—Nausea—Vinorelbine—hematologic cancer	0.000253	0.000295	CcSEcCtD
Propericiazine—Body temperature increased—Cisplatin—hematologic cancer	0.000253	0.000294	CcSEcCtD
Propericiazine—Thioproperazine—ALB—hematologic cancer	0.000252	0.0283	CrCbGaD
Propericiazine—Jaundice—Epirubicin—hematologic cancer	0.000251	0.000292	CcSEcCtD
Propericiazine—Vomiting—Thalidomide—hematologic cancer	0.000251	0.000292	CcSEcCtD
Propericiazine—Constipation—Etoposide—hematologic cancer	0.00025	0.000291	CcSEcCtD
Propericiazine—Rash—Thalidomide—hematologic cancer	0.000249	0.000289	CcSEcCtD
Propericiazine—Dermatitis—Thalidomide—hematologic cancer	0.000248	0.000289	CcSEcCtD
Propericiazine—Thiothixene—ALB—hematologic cancer	0.000248	0.0278	CrCbGaD
Propericiazine—Pipotiazine—ALB—hematologic cancer	0.000248	0.0278	CrCbGaD
Propericiazine—Diarrhoea—Vincristine—hematologic cancer	0.000247	0.000288	CcSEcCtD
Propericiazine—Photosensitivity reaction—Doxorubicin—hematologic cancer	0.000244	0.000284	CcSEcCtD
Propericiazine—Weight increased—Doxorubicin—hematologic cancer	0.000243	0.000283	CcSEcCtD
Propericiazine—Vision blurred—Prednisone—hematologic cancer	0.000242	0.000282	CcSEcCtD
Propericiazine—Nausea—Thiotepa—hematologic cancer	0.000242	0.000282	CcSEcCtD
Propericiazine—Oedema—Betamethasone—hematologic cancer	0.000241	0.00028	CcSEcCtD
Propericiazine—Oedema—Dexamethasone—hematologic cancer	0.000241	0.00028	CcSEcCtD
Propericiazine—Hyperglycaemia—Doxorubicin—hematologic cancer	0.000241	0.00028	CcSEcCtD
Propericiazine—Diarrhoea—Irinotecan—hematologic cancer	0.000241	0.00028	CcSEcCtD
Propericiazine—Diarrhoea—Mitoxantrone—hematologic cancer	0.000241	0.00028	CcSEcCtD
Propericiazine—Vomiting—Carmustine—hematologic cancer	0.000241	0.00028	CcSEcCtD
Propericiazine—Insomnia—Triamcinolone—hematologic cancer	0.00024	0.00028	CcSEcCtD
Propericiazine—Agranulocytosis—Epirubicin—hematologic cancer	0.00024	0.00028	CcSEcCtD
Propericiazine—Pneumonia—Doxorubicin—hematologic cancer	0.000239	0.000279	CcSEcCtD
Propericiazine—Infection—Dexamethasone—hematologic cancer	0.000239	0.000279	CcSEcCtD
Propericiazine—Infection—Betamethasone—hematologic cancer	0.000239	0.000279	CcSEcCtD
Propericiazine—Rash—Carmustine—hematologic cancer	0.000239	0.000278	CcSEcCtD
Propericiazine—Dermatitis—Carmustine—hematologic cancer	0.000238	0.000278	CcSEcCtD
Propericiazine—Vomiting—Alitretinoin—hematologic cancer	0.000238	0.000278	CcSEcCtD
Propericiazine—Drowsiness—Doxorubicin—hematologic cancer	0.000238	0.000277	CcSEcCtD
Propericiazine—Dyspnoea—Triamcinolone—hematologic cancer	0.000237	0.000276	CcSEcCtD
Propericiazine—Rash—Alitretinoin—hematologic cancer	0.000236	0.000275	CcSEcCtD
Propericiazine—Agitation—Prednisone—hematologic cancer	0.000236	0.000275	CcSEcCtD
Propericiazine—Dermatitis—Alitretinoin—hematologic cancer	0.000236	0.000275	CcSEcCtD
Propericiazine—Vomiting—Ifosfamide—hematologic cancer	0.000236	0.000274	CcSEcCtD
Propericiazine—Hypersensitivity—Cisplatin—hematologic cancer	0.000235	0.000274	CcSEcCtD
Propericiazine—Tachycardia—Betamethasone—hematologic cancer	0.000235	0.000274	CcSEcCtD
Propericiazine—Tachycardia—Dexamethasone—hematologic cancer	0.000235	0.000274	CcSEcCtD
Propericiazine—Angioedema—Prednisone—hematologic cancer	0.000235	0.000273	CcSEcCtD
Propericiazine—Diarrhoea—Gemcitabine—hematologic cancer	0.000235	0.000273	CcSEcCtD
Propericiazine—Nausea—Thalidomide—hematologic cancer	0.000234	0.000273	CcSEcCtD
Propericiazine—Rash—Ifosfamide—hematologic cancer	0.000234	0.000272	CcSEcCtD
Propericiazine—Dermatitis—Ifosfamide—hematologic cancer	0.000234	0.000272	CcSEcCtD
Propericiazine—Hyperhidrosis—Betamethasone—hematologic cancer	0.000233	0.000271	CcSEcCtD
Propericiazine—Hyperhidrosis—Dexamethasone—hematologic cancer	0.000233	0.000271	CcSEcCtD
Propericiazine—Jaundice—Doxorubicin—hematologic cancer	0.000232	0.00027	CcSEcCtD
Propericiazine—Body temperature increased—Etoposide—hematologic cancer	0.000231	0.000269	CcSEcCtD
Propericiazine—Vomiting—Vincristine—hematologic cancer	0.00023	0.000268	CcSEcCtD
Propericiazine—Cardiac disorder—Methotrexate—hematologic cancer	0.000229	0.000267	CcSEcCtD
Propericiazine—Rash—Vincristine—hematologic cancer	0.000228	0.000265	CcSEcCtD
Propericiazine—Dermatitis—Vincristine—hematologic cancer	0.000228	0.000265	CcSEcCtD
Propericiazine—Hypotension—Betamethasone—hematologic cancer	0.000225	0.000262	CcSEcCtD
Propericiazine—Hypotension—Dexamethasone—hematologic cancer	0.000225	0.000262	CcSEcCtD
Propericiazine—Nausea—Carmustine—hematologic cancer	0.000225	0.000262	CcSEcCtD
Propericiazine—Vomiting—Mitoxantrone—hematologic cancer	0.000224	0.000261	CcSEcCtD
Propericiazine—Vomiting—Irinotecan—hematologic cancer	0.000224	0.000261	CcSEcCtD
Propericiazine—Nausea—Alitretinoin—hematologic cancer	0.000223	0.000259	CcSEcCtD
Propericiazine—Agranulocytosis—Doxorubicin—hematologic cancer	0.000222	0.000259	CcSEcCtD
Propericiazine—Rash—Irinotecan—hematologic cancer	0.000222	0.000258	CcSEcCtD
Propericiazine—Rash—Mitoxantrone—hematologic cancer	0.000222	0.000258	CcSEcCtD
Propericiazine—Dermatitis—Irinotecan—hematologic cancer	0.000222	0.000258	CcSEcCtD
Propericiazine—Dermatitis—Mitoxantrone—hematologic cancer	0.000222	0.000258	CcSEcCtD
Propericiazine—Nausea—Ifosfamide—hematologic cancer	0.00022	0.000256	CcSEcCtD
Propericiazine—Diarrhoea—Cisplatin—hematologic cancer	0.000219	0.000255	CcSEcCtD
Propericiazine—Vomiting—Gemcitabine—hematologic cancer	0.000218	0.000254	CcSEcCtD
Propericiazine—Insomnia—Dexamethasone—hematologic cancer	0.000218	0.000254	CcSEcCtD
Propericiazine—Insomnia—Betamethasone—hematologic cancer	0.000218	0.000254	CcSEcCtD
Propericiazine—Rash—Gemcitabine—hematologic cancer	0.000216	0.000252	CcSEcCtD
Propericiazine—Dermatitis—Gemcitabine—hematologic cancer	0.000216	0.000251	CcSEcCtD
Propericiazine—Hypersensitivity—Etoposide—hematologic cancer	0.000216	0.000251	CcSEcCtD
Propericiazine—Nausea—Vincristine—hematologic cancer	0.000215	0.00025	CcSEcCtD
Propericiazine—Cardiac disorder—Epirubicin—hematologic cancer	0.000214	0.00025	CcSEcCtD
Propericiazine—Hypersensitivity—Prednisolone—hematologic cancer	0.000213	0.000248	CcSEcCtD
Propericiazine—Body temperature increased—Triamcinolone—hematologic cancer	0.00021	0.000244	CcSEcCtD
Propericiazine—Oedema—Prednisone—hematologic cancer	0.00021	0.000244	CcSEcCtD
Propericiazine—Nausea—Mitoxantrone—hematologic cancer	0.000209	0.000243	CcSEcCtD
Propericiazine—Nausea—Irinotecan—hematologic cancer	0.000209	0.000243	CcSEcCtD
Propericiazine—Infection—Prednisone—hematologic cancer	0.000208	0.000243	CcSEcCtD
Propericiazine—Arrhythmia—Epirubicin—hematologic cancer	0.000206	0.00024	CcSEcCtD
Propericiazine—Tachycardia—Prednisone—hematologic cancer	0.000205	0.000238	CcSEcCtD
Propericiazine—Fluphenazine—ABCB1—hematologic cancer	0.000205	0.0229	CrCbGaD
Propericiazine—Nausea—Gemcitabine—hematologic cancer	0.000204	0.000237	CcSEcCtD
Propericiazine—Vomiting—Cisplatin—hematologic cancer	0.000203	0.000237	CcSEcCtD
Propericiazine—Hyperhidrosis—Prednisone—hematologic cancer	0.000203	0.000236	CcSEcCtD
Propericiazine—Vision blurred—Methotrexate—hematologic cancer	0.000203	0.000236	CcSEcCtD
Propericiazine—Rash—Cisplatin—hematologic cancer	0.000201	0.000235	CcSEcCtD
Propericiazine—Dermatitis—Cisplatin—hematologic cancer	0.000201	0.000234	CcSEcCtD
Propericiazine—Diarrhoea—Etoposide—hematologic cancer	0.0002	0.000233	CcSEcCtD
Propericiazine—Cardiac disorder—Doxorubicin—hematologic cancer	0.000198	0.000231	CcSEcCtD
Propericiazine—Clomipramine—ALB—hematologic cancer	0.000196	0.022	CrCbGaD
Propericiazine—Hypersensitivity—Triamcinolone—hematologic cancer	0.000196	0.000228	CcSEcCtD
Propericiazine—Arrhythmia—Doxorubicin—hematologic cancer	0.000191	0.000222	CcSEcCtD
Propericiazine—Body temperature increased—Dexamethasone—hematologic cancer	0.00019	0.000222	CcSEcCtD
Propericiazine—Body temperature increased—Betamethasone—hematologic cancer	0.00019	0.000222	CcSEcCtD
Propericiazine—Nausea—Cisplatin—hematologic cancer	0.00019	0.000221	CcSEcCtD
Propericiazine—Insomnia—Prednisone—hematologic cancer	0.00019	0.000221	CcSEcCtD
Propericiazine—Vision blurred—Epirubicin—hematologic cancer	0.00019	0.000221	CcSEcCtD
Propericiazine—Clomipramine—ABCB1—hematologic cancer	0.000187	0.021	CrCbGaD
Propericiazine—Vomiting—Etoposide—hematologic cancer	0.000186	0.000217	CcSEcCtD
Propericiazine—Agitation—Epirubicin—hematologic cancer	0.000185	0.000215	CcSEcCtD
Propericiazine—Rash—Etoposide—hematologic cancer	0.000185	0.000215	CcSEcCtD
Propericiazine—Dermatitis—Etoposide—hematologic cancer	0.000184	0.000215	CcSEcCtD
Propericiazine—Rash—Prednisolone—hematologic cancer	0.000182	0.000212	CcSEcCtD
Propericiazine—Dermatitis—Prednisolone—hematologic cancer	0.000182	0.000212	CcSEcCtD
Propericiazine—Constipation—Prednisone—hematologic cancer	0.000179	0.000209	CcSEcCtD
Propericiazine—Confusional state—Methotrexate—hematologic cancer	0.000177	0.000206	CcSEcCtD
Propericiazine—Vision blurred—Doxorubicin—hematologic cancer	0.000175	0.000204	CcSEcCtD
Propericiazine—Infection—Methotrexate—hematologic cancer	0.000174	0.000203	CcSEcCtD
Propericiazine—Nausea—Etoposide—hematologic cancer	0.000174	0.000202	CcSEcCtD
Propericiazine—Nausea—Prednisolone—hematologic cancer	0.000172	0.0002	CcSEcCtD
Propericiazine—Agitation—Doxorubicin—hematologic cancer	0.000171	0.000199	CcSEcCtD
Propericiazine—Hyperhidrosis—Methotrexate—hematologic cancer	0.00017	0.000197	CcSEcCtD
Propericiazine—Vomiting—Triamcinolone—hematologic cancer	0.000169	0.000197	CcSEcCtD
Propericiazine—Rash—Triamcinolone—hematologic cancer	0.000167	0.000195	CcSEcCtD
Propericiazine—Dry mouth—Epirubicin—hematologic cancer	0.000167	0.000195	CcSEcCtD
Propericiazine—Dermatitis—Triamcinolone—hematologic cancer	0.000167	0.000195	CcSEcCtD
Propericiazine—Body temperature increased—Prednisone—hematologic cancer	0.000166	0.000193	CcSEcCtD
Propericiazine—Promethazine—ABCB1—hematologic cancer	0.000166	0.0186	CrCbGaD
Propericiazine—Confusional state—Epirubicin—hematologic cancer	0.000165	0.000193	CcSEcCtD
Propericiazine—Diarrhoea—Dexamethasone—hematologic cancer	0.000165	0.000192	CcSEcCtD
Propericiazine—Diarrhoea—Betamethasone—hematologic cancer	0.000165	0.000192	CcSEcCtD
Propericiazine—Oedema—Epirubicin—hematologic cancer	0.000164	0.000191	CcSEcCtD
Propericiazine—Hypotension—Methotrexate—hematologic cancer	0.000164	0.000191	CcSEcCtD
Propericiazine—Trifluoperazine—ABCB1—hematologic cancer	0.000164	0.0183	CrCbGaD
Propericiazine—Infection—Epirubicin—hematologic cancer	0.000163	0.00019	CcSEcCtD
Propericiazine—Tachycardia—Epirubicin—hematologic cancer	0.00016	0.000186	CcSEcCtD
Propericiazine—Quetiapine—ABCB1—hematologic cancer	0.000159	0.0178	CrCbGaD
Propericiazine—Hyperhidrosis—Epirubicin—hematologic cancer	0.000159	0.000185	CcSEcCtD
Propericiazine—Insomnia—Methotrexate—hematologic cancer	0.000159	0.000185	CcSEcCtD
Propericiazine—Nausea—Triamcinolone—hematologic cancer	0.000158	0.000184	CcSEcCtD
Propericiazine—Dyspnoea—Methotrexate—hematologic cancer	0.000156	0.000182	CcSEcCtD
Propericiazine—Somnolence—Methotrexate—hematologic cancer	0.000156	0.000181	CcSEcCtD
Propericiazine—Dry mouth—Doxorubicin—hematologic cancer	0.000155	0.00018	CcSEcCtD
Propericiazine—Hypersensitivity—Prednisone—hematologic cancer	0.000155	0.00018	CcSEcCtD
Propericiazine—Hypotension—Epirubicin—hematologic cancer	0.000153	0.000179	CcSEcCtD
Propericiazine—Vomiting—Betamethasone—hematologic cancer	0.000153	0.000178	CcSEcCtD
Propericiazine—Vomiting—Dexamethasone—hematologic cancer	0.000153	0.000178	CcSEcCtD
Propericiazine—Confusional state—Doxorubicin—hematologic cancer	0.000153	0.000178	CcSEcCtD
Propericiazine—Rash—Betamethasone—hematologic cancer	0.000152	0.000177	CcSEcCtD
Propericiazine—Rash—Dexamethasone—hematologic cancer	0.000152	0.000177	CcSEcCtD
Propericiazine—Oedema—Doxorubicin—hematologic cancer	0.000152	0.000177	CcSEcCtD
Propericiazine—Dermatitis—Dexamethasone—hematologic cancer	0.000152	0.000177	CcSEcCtD
Propericiazine—Dermatitis—Betamethasone—hematologic cancer	0.000152	0.000177	CcSEcCtD
Propericiazine—Infection—Doxorubicin—hematologic cancer	0.000151	0.000176	CcSEcCtD
Propericiazine—Insomnia—Epirubicin—hematologic cancer	0.000148	0.000173	CcSEcCtD
Propericiazine—Tachycardia—Doxorubicin—hematologic cancer	0.000148	0.000173	CcSEcCtD
Propericiazine—Hyperhidrosis—Doxorubicin—hematologic cancer	0.000147	0.000171	CcSEcCtD
Propericiazine—Dyspnoea—Epirubicin—hematologic cancer	0.000146	0.00017	CcSEcCtD
Propericiazine—Somnolence—Epirubicin—hematologic cancer	0.000146	0.00017	CcSEcCtD
Propericiazine—Diarrhoea—Prednisone—hematologic cancer	0.000144	0.000167	CcSEcCtD
Propericiazine—Nausea—Betamethasone—hematologic cancer	0.000143	0.000167	CcSEcCtD
Propericiazine—Nausea—Dexamethasone—hematologic cancer	0.000143	0.000167	CcSEcCtD
Propericiazine—Hypotension—Doxorubicin—hematologic cancer	0.000142	0.000165	CcSEcCtD
Propericiazine—Constipation—Epirubicin—hematologic cancer	0.00014	0.000163	CcSEcCtD
Propericiazine—Body temperature increased—Methotrexate—hematologic cancer	0.000139	0.000161	CcSEcCtD
Propericiazine—Insomnia—Doxorubicin—hematologic cancer	0.000137	0.00016	CcSEcCtD
Propericiazine—Dyspnoea—Doxorubicin—hematologic cancer	0.000135	0.000158	CcSEcCtD
Propericiazine—Somnolence—Doxorubicin—hematologic cancer	0.000135	0.000157	CcSEcCtD
Propericiazine—Chlorpromazine—ALB—hematologic cancer	0.000135	0.0151	CrCbGaD
Propericiazine—Vomiting—Prednisone—hematologic cancer	0.000133	0.000155	CcSEcCtD
Propericiazine—Rash—Prednisone—hematologic cancer	0.000132	0.000154	CcSEcCtD
Propericiazine—Dermatitis—Prednisone—hematologic cancer	0.000132	0.000154	CcSEcCtD
Propericiazine—Constipation—Doxorubicin—hematologic cancer	0.00013	0.000151	CcSEcCtD
Propericiazine—Body temperature increased—Epirubicin—hematologic cancer	0.00013	0.000151	CcSEcCtD
Propericiazine—Hypersensitivity—Methotrexate—hematologic cancer	0.000129	0.00015	CcSEcCtD
Propericiazine—Chlorpromazine—ABCB1—hematologic cancer	0.000128	0.0144	CrCbGaD
Propericiazine—Nausea—Prednisone—hematologic cancer	0.000125	0.000145	CcSEcCtD
Propericiazine—Hypersensitivity—Epirubicin—hematologic cancer	0.000121	0.000141	CcSEcCtD
Propericiazine—Body temperature increased—Doxorubicin—hematologic cancer	0.00012	0.00014	CcSEcCtD
Propericiazine—Diarrhoea—Methotrexate—hematologic cancer	0.00012	0.00014	CcSEcCtD
Propericiazine—Diarrhoea—Epirubicin—hematologic cancer	0.000112	0.000131	CcSEcCtD
Propericiazine—Hypersensitivity—Doxorubicin—hematologic cancer	0.000112	0.00013	CcSEcCtD
Propericiazine—Vomiting—Methotrexate—hematologic cancer	0.000111	0.00013	CcSEcCtD
Propericiazine—Rash—Methotrexate—hematologic cancer	0.000111	0.000129	CcSEcCtD
Propericiazine—Dermatitis—Methotrexate—hematologic cancer	0.00011	0.000129	CcSEcCtD
Propericiazine—Vomiting—Epirubicin—hematologic cancer	0.000104	0.000121	CcSEcCtD
Propericiazine—Nausea—Methotrexate—hematologic cancer	0.000104	0.000121	CcSEcCtD
Propericiazine—Diarrhoea—Doxorubicin—hematologic cancer	0.000104	0.000121	CcSEcCtD
Propericiazine—Rash—Epirubicin—hematologic cancer	0.000103	0.00012	CcSEcCtD
Propericiazine—Dermatitis—Epirubicin—hematologic cancer	0.000103	0.00012	CcSEcCtD
Propericiazine—Nausea—Epirubicin—hematologic cancer	9.75e-05	0.000113	CcSEcCtD
Propericiazine—Vomiting—Doxorubicin—hematologic cancer	9.65e-05	0.000112	CcSEcCtD
Propericiazine—Rash—Doxorubicin—hematologic cancer	9.57e-05	0.000111	CcSEcCtD
Propericiazine—Dermatitis—Doxorubicin—hematologic cancer	9.57e-05	0.000111	CcSEcCtD
Propericiazine—Nausea—Doxorubicin—hematologic cancer	9.02e-05	0.000105	CcSEcCtD
Propericiazine—ADRA1B—GPCR downstream signaling—PIK3CB—hematologic cancer	3.19e-05	0.000242	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—CDKN2B—hematologic cancer	3.17e-05	0.00024	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—PDGFB—hematologic cancer	3.16e-05	0.000239	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—IL3—hematologic cancer	3.16e-05	0.000239	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—PIK3R1—hematologic cancer	3.14e-05	0.000238	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—PIK3CG—hematologic cancer	3.12e-05	0.000236	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—PTPN1—hematologic cancer	3.11e-05	0.000235	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—TSC2—hematologic cancer	3.09e-05	0.000234	CbGpPWpGaD
Propericiazine—ADRA2A—Hemostasis—MAPK3—hematologic cancer	3.08e-05	0.000233	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—CD86—hematologic cancer	3.07e-05	0.000232	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—PTPN11—hematologic cancer	3.07e-05	0.000232	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—ABCB1—hematologic cancer	3.06e-05	0.000232	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—RASGRP1—hematologic cancer	3.06e-05	0.000231	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—JAK2—hematologic cancer	3.05e-05	0.000231	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—HSP90AA1—hematologic cancer	3.05e-05	0.000231	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—SYK—hematologic cancer	3.05e-05	0.000231	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—HES1—hematologic cancer	3.03e-05	0.000229	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR downstream signaling—PIK3CD—hematologic cancer	3.02e-05	0.000229	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—NCOR1—hematologic cancer	3.01e-05	0.000228	CbGpPWpGaD
Propericiazine—ADRA2A—Hemostasis—TGFB1—hematologic cancer	2.99e-05	0.000226	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—FGF1—hematologic cancer	2.98e-05	0.000225	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—CSF2—hematologic cancer	2.98e-05	0.000225	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—FGFR3—hematologic cancer	2.97e-05	0.000225	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—CREB1—hematologic cancer	2.97e-05	0.000225	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—NCOR1—hematologic cancer	2.97e-05	0.000225	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—GSTM1—hematologic cancer	2.97e-05	0.000225	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—MAPK14—hematologic cancer	2.94e-05	0.000223	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—STAT1—hematologic cancer	2.94e-05	0.000222	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—FOXO1—hematologic cancer	2.93e-05	0.000222	CbGpPWpGaD
Propericiazine—ADRA1B—GPCR downstream signaling—IL2—hematologic cancer	2.93e-05	0.000222	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—PDGFRB—hematologic cancer	2.93e-05	0.000222	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—CCL2—hematologic cancer	2.91e-05	0.00022	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—IL6R—hematologic cancer	2.9e-05	0.00022	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—PIK3CB—hematologic cancer	2.9e-05	0.000219	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—ESR1—hematologic cancer	2.89e-05	0.000219	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—PDGFRA—hematologic cancer	2.88e-05	0.000218	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—JAK1—hematologic cancer	2.87e-05	0.000217	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—PRKCG—hematologic cancer	2.87e-05	0.000217	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR downstream signaling—PIK3R1—hematologic cancer	2.85e-05	0.000216	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—FN1—hematologic cancer	2.85e-05	0.000216	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—BAD—hematologic cancer	2.82e-05	0.000213	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—NFKBIA—hematologic cancer	2.82e-05	0.000213	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—NOTCH1—hematologic cancer	2.79e-05	0.000211	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR downstream signaling—JAK2—hematologic cancer	2.77e-05	0.00021	CbGpPWpGaD
Propericiazine—ADRA2A—Hemostasis—KRAS—hematologic cancer	2.77e-05	0.000209	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—MAP2K1—hematologic cancer	2.76e-05	0.000209	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—GRB2—hematologic cancer	2.75e-05	0.000208	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—PIK3CD—hematologic cancer	2.74e-05	0.000208	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—PDGFA—hematologic cancer	2.74e-05	0.000208	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—CD80—hematologic cancer	2.73e-05	0.000207	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—PIK3CG—hematologic cancer	2.73e-05	0.000207	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—KIT—hematologic cancer	2.73e-05	0.000207	CbGpPWpGaD
Propericiazine—DRD1—Signaling by GPCR—NRAS—hematologic cancer	2.73e-05	0.000207	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—KITLG—hematologic cancer	2.7e-05	0.000205	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—IL2RA—hematologic cancer	2.68e-05	0.000203	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—PTPN11—hematologic cancer	2.68e-05	0.000203	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—IL2—hematologic cancer	2.66e-05	0.000202	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—TERT—hematologic cancer	2.65e-05	0.000201	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—STAT5A—hematologic cancer	2.64e-05	0.0002	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR downstream signaling—PIK3CB—hematologic cancer	2.63e-05	0.000199	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—MTHFR—hematologic cancer	2.63e-05	0.000199	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—CDKN2B—hematologic cancer	2.62e-05	0.000198	CbGpPWpGaD
Propericiazine—DRD1—Signaling by GPCR—MAPK3—hematologic cancer	2.61e-05	0.000198	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—CREB1—hematologic cancer	2.6e-05	0.000197	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—PIK3R1—hematologic cancer	2.59e-05	0.000196	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—PDGFB—hematologic cancer	2.59e-05	0.000196	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—BRAF—hematologic cancer	2.56e-05	0.000194	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—CCL2—hematologic cancer	2.54e-05	0.000192	CbGpPWpGaD
Propericiazine—ADRA2A—Hemostasis—PIK3CA—hematologic cancer	2.54e-05	0.000192	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—IL6R—hematologic cancer	2.53e-05	0.000192	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—CD86—hematologic cancer	2.53e-05	0.000192	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—TSC2—hematologic cancer	2.53e-05	0.000192	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—CREBBP—hematologic cancer	2.53e-05	0.000192	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—JAK2—hematologic cancer	2.52e-05	0.000191	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—HES1—hematologic cancer	2.5e-05	0.000189	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—NCOR1—hematologic cancer	2.48e-05	0.000188	CbGpPWpGaD
Propericiazine—ADRA2A—Hemostasis—TP53—hematologic cancer	2.46e-05	0.000186	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—CSF2—hematologic cancer	2.46e-05	0.000186	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—FGF1—hematologic cancer	2.46e-05	0.000186	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—FGFR3—hematologic cancer	2.43e-05	0.000184	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—FOXO1—hematologic cancer	2.42e-05	0.000183	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR downstream signaling—IL2—hematologic cancer	2.42e-05	0.000183	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—PDGFRB—hematologic cancer	2.42e-05	0.000183	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—MAP2K1—hematologic cancer	2.41e-05	0.000183	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—MAPK14—hematologic cancer	2.41e-05	0.000182	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—PIK3CD—hematologic cancer	2.4e-05	0.000182	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—PIK3CB—hematologic cancer	2.39e-05	0.000181	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—PDGFRA—hematologic cancer	2.38e-05	0.00018	CbGpPWpGaD
Propericiazine—DRD1—GPCR downstream signaling—PIK3CA—hematologic cancer	2.38e-05	0.00018	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—JAK1—hematologic cancer	2.37e-05	0.000179	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—PRKCG—hematologic cancer	2.37e-05	0.000179	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—ESR1—hematologic cancer	2.36e-05	0.000179	CbGpPWpGaD
Propericiazine—ADRA2A—Hemostasis—HRAS—hematologic cancer	2.35e-05	0.000178	CbGpPWpGaD
Propericiazine—DRD1—Signaling by GPCR—KRAS—hematologic cancer	2.35e-05	0.000178	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—FN1—hematologic cancer	2.34e-05	0.000177	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—NFKBIA—hematologic cancer	2.31e-05	0.000175	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—BAD—hematologic cancer	2.31e-05	0.000175	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—FGF2—hematologic cancer	2.3e-05	0.000174	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—NOTCH1—hematologic cancer	2.29e-05	0.000173	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—PIK3R1—hematologic cancer	2.27e-05	0.000172	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—CD80—hematologic cancer	2.24e-05	0.00017	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—PIK3CG—hematologic cancer	2.23e-05	0.000169	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—KIT—hematologic cancer	2.23e-05	0.000169	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—NRAS—hematologic cancer	2.23e-05	0.000169	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—IL2RA—hematologic cancer	2.21e-05	0.000168	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—PIK3CG—hematologic cancer	2.21e-05	0.000167	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—JAK2—hematologic cancer	2.2e-05	0.000167	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—IL2—hematologic cancer	2.2e-05	0.000166	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—PTPN11—hematologic cancer	2.2e-05	0.000166	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—TERT—hematologic cancer	2.19e-05	0.000166	CbGpPWpGaD
Propericiazine—DRD1—Signaling by GPCR—PIK3CA—hematologic cancer	2.16e-05	0.000163	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—MDM2—hematologic cancer	2.15e-05	0.000163	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—MAPK3—hematologic cancer	2.14e-05	0.000162	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—PDGFB—hematologic cancer	2.14e-05	0.000162	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—CREB1—hematologic cancer	2.13e-05	0.000161	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—BRAF—hematologic cancer	2.1e-05	0.000159	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—MTOR—hematologic cancer	2.09e-05	0.000158	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—PIK3CB—hematologic cancer	2.09e-05	0.000158	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—TSC2—hematologic cancer	2.09e-05	0.000158	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—CCL2—hematologic cancer	2.08e-05	0.000158	CbGpPWpGaD
Propericiazine—ADRA2A—Hemostasis—AKT1—hematologic cancer	2.08e-05	0.000157	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—IL6R—hematologic cancer	2.07e-05	0.000157	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—CREBBP—hematologic cancer	2.07e-05	0.000157	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—CREBBP—hematologic cancer	2.04e-05	0.000155	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—FGFR3—hematologic cancer	2.01e-05	0.000152	CbGpPWpGaD
Propericiazine—DRD1—Signaling by GPCR—HRAS—hematologic cancer	2e-05	0.000151	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—MAPK14—hematologic cancer	1.99e-05	0.000151	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—MAP2K1—hematologic cancer	1.98e-05	0.00015	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—PIK3CD—hematologic cancer	1.96e-05	0.000149	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—CDKN1B—hematologic cancer	1.96e-05	0.000149	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—ESR1—hematologic cancer	1.95e-05	0.000148	CbGpPWpGaD
Propericiazine—ADRA1B—GPCR downstream signaling—PIK3CA—hematologic cancer	1.95e-05	0.000147	CbGpPWpGaD
Propericiazine—DRD1—GPCR downstream signaling—AKT1—hematologic cancer	1.94e-05	0.000147	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—PIK3CD—hematologic cancer	1.94e-05	0.000147	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—FN1—hematologic cancer	1.93e-05	0.000146	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—KRAS—hematologic cancer	1.92e-05	0.000146	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—CASP3—hematologic cancer	1.92e-05	0.000146	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—IL2—hematologic cancer	1.92e-05	0.000145	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—ALB—hematologic cancer	1.91e-05	0.000145	CbGpPWpGaD
Propericiazine—DRD1—Signaling by GPCR—IL6—hematologic cancer	1.91e-05	0.000145	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—BAD—hematologic cancer	1.9e-05	0.000144	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—NFKBIA—hematologic cancer	1.9e-05	0.000144	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—NOTCH1—hematologic cancer	1.89e-05	0.000143	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—FGF2—hematologic cancer	1.88e-05	0.000142	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—CCND1—hematologic cancer	1.87e-05	0.000142	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—JUN—hematologic cancer	1.87e-05	0.000141	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—PIK3R1—hematologic cancer	1.85e-05	0.00014	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—CD80—hematologic cancer	1.85e-05	0.00014	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—KIT—hematologic cancer	1.84e-05	0.00014	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—PIK3CG—hematologic cancer	1.84e-05	0.00014	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—NRAS—hematologic cancer	1.84e-05	0.00014	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—PIK3R1—hematologic cancer	1.83e-05	0.000139	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—PTPN11—hematologic cancer	1.81e-05	0.000137	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—CDKN1A—hematologic cancer	1.81e-05	0.000137	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—PTEN—hematologic cancer	1.81e-05	0.000137	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—JAK2—hematologic cancer	1.8e-05	0.000137	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—MAPK8—hematologic cancer	1.77e-05	0.000134	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—PIK3CA—hematologic cancer	1.77e-05	0.000134	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—MAPK3—hematologic cancer	1.77e-05	0.000134	CbGpPWpGaD
Propericiazine—DRD1—Signaling by GPCR—AKT1—hematologic cancer	1.76e-05	0.000133	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—MDM2—hematologic cancer	1.76e-05	0.000133	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—CREB1—hematologic cancer	1.76e-05	0.000133	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—BRAF—hematologic cancer	1.73e-05	0.000131	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—EP300—hematologic cancer	1.72e-05	0.00013	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—CCL2—hematologic cancer	1.72e-05	0.00013	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—IL6R—hematologic cancer	1.71e-05	0.00013	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—MTOR—hematologic cancer	1.71e-05	0.00013	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—PIK3CB—hematologic cancer	1.71e-05	0.00013	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—CREBBP—hematologic cancer	1.71e-05	0.000129	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—PIK3CB—hematologic cancer	1.69e-05	0.000128	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—SRC—hematologic cancer	1.68e-05	0.000127	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—HRAS—hematologic cancer	1.63e-05	0.000124	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—MAP2K1—hematologic cancer	1.63e-05	0.000124	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—VEGFA—hematologic cancer	1.63e-05	0.000124	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—PIK3CD—hematologic cancer	1.62e-05	0.000123	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—STAT3—hematologic cancer	1.62e-05	0.000122	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—NRAS—hematologic cancer	1.61e-05	0.000122	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—CDKN1B—hematologic cancer	1.61e-05	0.000122	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR downstream signaling—PIK3CA—hematologic cancer	1.61e-05	0.000122	CbGpPWpGaD
Propericiazine—ADRA1B—GPCR downstream signaling—AKT1—hematologic cancer	1.59e-05	0.00012	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—KRAS—hematologic cancer	1.59e-05	0.00012	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—CASP3—hematologic cancer	1.57e-05	0.000119	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—IL2—hematologic cancer	1.57e-05	0.000119	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—IL6—hematologic cancer	1.56e-05	0.000118	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—FGF2—hematologic cancer	1.55e-05	0.000118	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—MAPK3—hematologic cancer	1.54e-05	0.000117	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—CCND1—hematologic cancer	1.53e-05	0.000116	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—PIK3R1—hematologic cancer	1.53e-05	0.000116	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—JUN—hematologic cancer	1.53e-05	0.000116	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—MYC—hematologic cancer	1.5e-05	0.000114	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—TGFB1—hematologic cancer	1.5e-05	0.000113	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—JAK2—hematologic cancer	1.49e-05	0.000113	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—CDKN1A—hematologic cancer	1.48e-05	0.000112	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—PTEN—hematologic cancer	1.48e-05	0.000112	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—PTEN—hematologic cancer	1.46e-05	0.000111	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—PIK3CA—hematologic cancer	1.46e-05	0.00011	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—MDM2—hematologic cancer	1.45e-05	0.00011	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—MAPK8—hematologic cancer	1.45e-05	0.00011	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—AKT1—hematologic cancer	1.44e-05	0.000109	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—PIK3CB—hematologic cancer	1.41e-05	0.000107	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—MTOR—hematologic cancer	1.41e-05	0.000107	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—EP300—hematologic cancer	1.41e-05	0.000107	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—EP300—hematologic cancer	1.39e-05	0.000105	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—KRAS—hematologic cancer	1.39e-05	0.000105	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—SRC—hematologic cancer	1.37e-05	0.000104	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—HRAS—hematologic cancer	1.35e-05	0.000102	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—VEGFA—hematologic cancer	1.34e-05	0.000101	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—CDKN1B—hematologic cancer	1.33e-05	0.0001	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—STAT3—hematologic cancer	1.32e-05	0.0001	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—NRAS—hematologic cancer	1.32e-05	0.0001	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR downstream signaling—AKT1—hematologic cancer	1.31e-05	9.93e-05	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—CASP3—hematologic cancer	1.3e-05	9.84e-05	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—IL2—hematologic cancer	1.3e-05	9.83e-05	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—IL6—hematologic cancer	1.29e-05	9.78e-05	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—PIK3CA—hematologic cancer	1.27e-05	9.65e-05	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—CCND1—hematologic cancer	1.27e-05	9.58e-05	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—MAPK3—hematologic cancer	1.26e-05	9.57e-05	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—JUN—hematologic cancer	1.26e-05	9.56e-05	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—TP53—hematologic cancer	1.23e-05	9.34e-05	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—MYC—hematologic cancer	1.23e-05	9.31e-05	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—TGFB1—hematologic cancer	1.23e-05	9.29e-05	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—CDKN1A—hematologic cancer	1.22e-05	9.27e-05	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—PTEN—hematologic cancer	1.22e-05	9.25e-05	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—MAPK8—hematologic cancer	1.19e-05	9.05e-05	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—AKT1—hematologic cancer	1.19e-05	9.02e-05	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—HRAS—hematologic cancer	1.18e-05	8.93e-05	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—EP300—hematologic cancer	1.16e-05	8.82e-05	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—KRAS—hematologic cancer	1.14e-05	8.6e-05	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—SRC—hematologic cancer	1.13e-05	8.57e-05	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—IL6—hematologic cancer	1.13e-05	8.55e-05	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—VEGFA—hematologic cancer	1.1e-05	8.35e-05	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—STAT3—hematologic cancer	1.09e-05	8.27e-05	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—NRAS—hematologic cancer	1.09e-05	8.25e-05	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—PIK3CA—hematologic cancer	1.04e-05	7.9e-05	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—MAPK3—hematologic cancer	1.04e-05	7.9e-05	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—AKT1—hematologic cancer	1.04e-05	7.88e-05	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—PIK3CA—hematologic cancer	1.03e-05	7.8e-05	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—MYC—hematologic cancer	1.01e-05	7.68e-05	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—TGFB1—hematologic cancer	1.01e-05	7.67e-05	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—TP53—hematologic cancer	1.01e-05	7.65e-05	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—HRAS—hematologic cancer	9.66e-06	7.31e-05	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—KRAS—hematologic cancer	9.38e-06	7.1e-05	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—IL6—hematologic cancer	9.24e-06	7e-05	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—PIK3CA—hematologic cancer	8.61e-06	6.52e-05	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—AKT1—hematologic cancer	8.53e-06	6.46e-05	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—AKT1—hematologic cancer	8.42e-06	6.37e-05	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—TP53—hematologic cancer	8.33e-06	6.31e-05	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—HRAS—hematologic cancer	7.97e-06	6.03e-05	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—IL6—hematologic cancer	7.63e-06	5.78e-05	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—AKT1—hematologic cancer	7.04e-06	5.33e-05	CbGpPWpGaD
